Talking Meds - A PrescQIPP podcast
Engaging conversations about medicines-related dilemmas.
Talking Meds is hosted by Jonathan Underhill who, every two weeks, will chat to a fantastic guest about current medical issues and clinical dilemmas.
Jonathan has a background as a hospital clinical pharmacist but worked for many years at the National Prescribing Centre (NPC) developing innovative ways of teaching therapeutics, evidence-based medicine and clinical decision making to prescribers and their support teams. Until recently, he worked at NICE as a consultant clinical adviser in their Medicines Optimisation Team. He is now Medicines Clinical Adviser at PrescQIPP.
Jonathan and his guests will discuss topics such as new guidance from NICE on menopause, asthma, depression deprescribing and insomnia; how to tackle penicillin allergy de-labelling.
There will also be a series on ’Sensible prescribing in Older people with Jonathan and Lucy’, with consultant geriatrician and author Lucy Pollock.
PrescQIPP is a Community Interest Company. We operate on a not-for-profit basis for the benefit of NHS patients and organisations and help NHS organisations to improve medicines-related care to patients. Find out more here: https://www.prescqipp.info/
Talking Meds - A PrescQIPP podcast
16. Management of obesity with Philip Newland-Jones
Welcome to the latest episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. Today, your host Jonathan Underhill, Medicines Clinical Adviser at PrescQIPP, talks to Philip Newland-Jones about new treatments for obesity and the updated NICE guideline from January 2025.
Philip is a Consultant Pharmacist in Diabetes and Endocrinology and leads a large dynamic team at University Hospital Southampton. He works at a National level on various committees including being the lead pharmacist for the NHS England Diabetes and Endocrinology Clinical Reference Group.
Jonathan and Philip discuss various challenging and sometimes controversial issues around the management of obesity. The evidence for the effectiveness of some of the medicines options is impressive, but they are not without side effects - careful and appropriate use is key. Many new medicines are in development and Philip gives us an insight into what we can expect on the horizon.
PrescQIPP resources mentioned in this episode:
- Bulletin 323: Bariatric surgery July 2023
- PrescQIPP Prescribing Mastery; Prescribing Hot topics 26th March 2025
Useful NICE obesity resources:
- Tirzepatide: local formulary information
- A practical guide to using medicines to manage overweight and obesity
Other resources mentioned in this episode:
A new episode of Talking Meds will be available every other Friday.
If you have feedback or suggestions for future topics and guests please submit them to talkingmeds@prescqipp.info
PrescQIPP is funded by the NHS for the NHS, and our aim is to improve medicines-related care for patients. We do this by producing high quality evidence-based resources and training, and by facilitating networks between NHS organisations and professionals.
The majority of pharmacists and other healthcare professionals across the UK can access our resources by registering and logging on to our website. If you have any difficulty accessing the website you can email help@prescqipp.info and we’ll aim to sort things out for you.
Find out more about PrescQIPP here